References
- Picken MM. Amyloidosis-where are we now and where are we heading? Arch Pathol Lab Med. 2010;134(4):545–551. doi:10.1043/1543-2165-134.4.545.
- Sipe JD, Benson MD, Buxbaum JN, et al. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21(4):221–224.doi:10.3109/13506129.2014.964858.
- Pepys MB. Amyloidosis. Annu Rev Med. 2006;57(1):223–241. doi:10.1146/annurev.med.57.121304.131243.
- Taban M, Piva A, See RF, Sadun AA, Quiros PA. Review: orbital amyloidosis. Ophthal Plast Reconstr Surg. 2004;20:162–165.
- Hazenberg BPC. Amyloidosis. Rheum Dis Clin N Am. 2013;39(2):323–345. doi:10.1016/j.rdc.2013.02.012.
- Olsen KE, Sandgren O, Sletten K, Westermark P. Primary localized amyloidosis of the eyelid: two cases of immunoglobulin light chain-derived proteins, subtype lambda V respectively lambda VI. Clin Exp Immunol. 1996;106(2):362–366. doi:10.1046/j.1365-2249.1996.d01-830.x.
- Aryasit O, Preechawai P, Kayasut K. Clinical presentation, treatment, and prognosis of periocular and orbital amyloidosis in a university-based referral center. Clin Ophthalmol Auckl NZ. 2013;7:801–805. doi:10.2147/OPTH.S41857.
- Dithmar S, Linke RP, Kolling G, Völcker HE, Helmke B. Ptosis from localized A-λ-amyloid deposits in the levator palpebrae muscle. Ophthalmology. 2004;111(5):1043–1047. doi:10.1016/j.ophtha.2003.09.032.
- Mora-Horna ER, Rojas-Padilla R, López VG, Guzmán MJ, Ceriotto A, Salcedo G. Ocular adnexal and orbital amyloidosis: a case series and literature review. Int Ophthalmol. 2016;36(2):281–298. doi:10.1007/s10792-015-0138-7.
- Marcet MM, Roh JH, Mandeville JT, Woog JJ. Localized orbital amyloidosis involving the lacrimal sac and nasolacrimal duct. Ophthalmology. 2006;113(1):153–156. doi:10.1016/j.ophtha.2005.09.034.
- Leibovitch I, Selva D, Goldberg RA, et al. Periocular and orbital amyloidosis: clinical characteristics, management, and outcome. Ophthalmology. 2006;113(9):1657–1664.doi:10.1016/j.ophtha.2006.03.052.
- Murdoch IE, Sullivan TJ, Moseley I, et al. Primary localised amyloidosis of the orbit. Br J Ophthalmol. 1996;80(12):1083–1086. doi:10.1136/bjo.80.12.1083.
- Lee H-J, Chang S-E, Lee M-W, Choi J-H, Moon K-C. Systemic amyloidosis associated with multiple myeloma presenting as periorbital purpura. J Dermatol. 2008;35(6):371–372. doi:10.1111/j.1346-8138.2008.00487.x.
- Goshe JM, Schoenfield L, Emch T, Singh AD. Myeloma-associated orbital amyloidosis. Orbit Amst Neth. 2010;29(5):274–277. doi:10.3109/01676831003660671.
- Brown G, Shapeero LG, Weiss BM, Roschewski M. Multiple myeloma with lacrimal gland amyloidosis and sarcoidosis. Am J Hematol. 2010;85(7):506–509. doi:10.1002/ajh.21695.
- Khaira M, Mutamba A, Meligonis G, Rose GE, Plowman PN, O’Donnell H. The use of radiotherapy for the treatment of localized orbital amyloidosis. Orbit. 2008;27(6):432–437. doi:10.1080/01676830802350216.
- Mehta N, Schoder H, Chiu A, Schoolmeester JK, Portlock C. Adnexal mass secondary to extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with associated amyloid deposition. Case Rep. 2014;bcr2014206699–bcr2014206699. [ 2014(nov14 1)]. doi:10.1136/bcr-2014-206699.